Stock screenerAll disclosures →
EDGAR →
RYTM
Conviction 61HealthcareScan · Thu, Jun 25, 2026RYTM$108.24+0.64%
ResistanceSupportVol 14Insider sellVol MA14 1.05M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price108.24
Change+0.64%
Gap+0.07%
Rel volume1.19×
Avg volume892.4K
Avg $ vol84.26M
SMA 2092.16
SMA 5089.93
SMA 20097.84
Price vs 50+20.36%
Price vs 200+10.63%
MA stackmixed
50/200 cross—
Supertrendup · 93.87
RSI (14)76
MACD hist2.30
MACD crossbull · 7d
Stoch %K / %D87 / 90
ADX (14)29
+DI / −DI42 / 9
RSI divergence—
MACD divergence—
ATR %+4.51%
ADR %4.95%
52w high117.62
52w low61.45
From 52w high-7.97%
Above 52w low+76.16%
New 52w highNo
SqueezeOff
Bollinger width33.08%
%B1.03
Donchian pos88.20%
Donchian high111.63
Donchian low82.89
AVWAP (52w high)95.91
vs AVWAP high+12.86%
AVWAP (52w low)95.87
vs AVWAP low+12.90%
OBV trendUp
Chaikin MF (20)-0.10
Today vs 20d1.19×
Avg vol (14d)1.05M
Avg vol (20d)892.4K
Avg $ vol (20d)84.26M
Market cap7.42B
RS 3m (vs SPY)+17.96%
RS 6m (vs SPY)-11.83%
RS line new highYes
Trend template5/8
Technical rank68.7
1 week+12.95%
1 month+20.51%
3 months+27.91%
6 months-4.11%
1 year+70.03%
YTD+3.08%
P/E-37.74
P/B60.35
P/S39.09
P/FCF-63.60
EPS-3.11
Div yield—
ROE-159.91%
ROA-44.43%
Debt/Eq0.88
Current4.17
EV/EBITDA-38.97
Gross margin—
Net margin-103.57%
Rev growth45.83%
EPS growth24.58%
Price target137.75
Target upside27.26%
Analyst ratingBuy
Institutional116.43%
Ent. value7.46B
Revenue60.11M
Net income-55.64M
Gross profit—
Free cash flow-116.63M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out68.53M
Employees414
ListedThu, Oct 5, 2017
Free float61.13M
Float %89.2%
Short interest7.91M
Days to cover14.8d
Short volume52.9%
Squeeze score62 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$0.82 · 5 est
Last EPS vs est−$0.83 vs −$0.86
Last surprise+3.5% beat
Setup gradeB
Conviction61 / 100
Pattern quality—
Tech rank68.7 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance98.69
Support81.15
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RYTM
No recent disclosed trades by Congress in RYTM. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in RYTM · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
JEAN CHRISTOPHE Director · Restricted Stock Units · 2026-06-24 | Grant | 2.32K | — | 2026-06-24 | 2026-06-25 |
GOOD JENNIFER L Director · Stock Option (right to buy) · 2026-06-24 | Grant | 3.69K | — | 2026-06-24 | 2026-06-25 |
GOOD JENNIFER L Director · Restricted Stock Units · 2026-06-24 | Grant | 2.32K | — | 2026-06-24 | 2026-06-25 |
MCGIRR DAVID W J Director · Stock Option (right to buy) · 2026-06-24 | Grant | 3.69K | — | 2026-06-24 | 2026-06-25 |
MCGIRR DAVID W J Director · Restricted Stock Units · 2026-06-24 | Grant | 2.32K | — | 2026-06-24 | 2026-06-25 |
TETRAULT LYNN A. Director · Stock Option (right to buy) · 2026-06-24 | Grant | 3.69K | — | 2026-06-24 | 2026-06-25 |
TETRAULT LYNN A. Director · Restricted Stock Units · 2026-06-24 | Grant | 2.32K | — | 2026-06-24 | 2026-06-25 |
Arbuckle Stuart A Director · Stock Option (right to buy) · 2026-06-24 | Grant | 3.69K | — | 2026-06-24 | 2026-06-25 |
Arbuckle Stuart A Director · Restricted Stock Units · 2026-06-24 | Grant | 2.32K | — | 2026-06-24 | 2026-06-25 |
JEAN CHRISTOPHE Director · Stock Option (right to buy) · 2026-06-24 | Grant | 3.69K | — | 2026-06-24 | 2026-06-25 |
SEC filings
EDGAR filings in RYTM · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.